Iridium Appoints Louis Alterman to Board of Directors
MCLEAN, Va., Dec. 4, 2025 /PRNewswire/ -- Iridium Communications Inc. (Nasdaq: IRDM),…
TERREPOWER Appoints Brandon Handy as Chief People Officer
DALLAS, Dec. 2, 2025 /PRNewswire/ -- TERREPOWER today announced that Brandon Handy has…
Signing Day Sports Shareholder Letter Details AI/HPC Infrastructure Opportunity with BlockchAIn Digital Infrastructure
SCOTTSDALE, AZ, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc.…
Token Cat Limited Appoints Renowned Blockchain Expert Sav Persico as Chief Operating Officer to Accelerate the Company’s Cryptocurrency and crypto Asset Transformation Strategy
BEIJING, Nov. 26, 2025 /PRNewswire/ -- Token Cat Limited (Nasdaq: TC, the…
Vehere Elevates Sanjay Bhardwaj to Managing Director, India and ASEAN
NEW DELHI, Sept. 12, 2025 /PRNewswire/ -- Vehere, a leader in AI-powered Cyber…
Nilesh Shah joins Illumina as Head of Region, AMEA
SINGAPORE, Aug. 19, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global…
SimCorp names Peter Sanderson as Chief Executive Officer
Sanderson has proven track record of driving growth and deep industry knowledge Sanderson…
A New Chapter of Bold Leadership and Unstoppable Growth
LEHI, Utah, July 24, 2025 /PRNewswire/ -- Amare Global, The Mental Wellness…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients](https://i1.wp.com/ml-eu.globenewswire.com/media/NTJlMDkyZjktNGMwNi00N2YyLTkyZmQtZTIwMWJlNzgxOWYyLTEwMTI2MjEtMjAyNS0wNi0xNS1lbg==/tiny/F-Hoffmann-La-Roche-Ltd.png?w=420&resize=420,280&ssl=1 "[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients")
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
After a thorough clinical review, the benefit-risk for the use of Elevidys…
Early Warning Press Release Respecting the Acquisition of Common Shares of RAMM PHARMA Corp.
TORONTO, May 30, 2025 (GLOBE NEWSWIRE) -- Jack Burnett ("CEO") today announced…